Fundraising Fox
Altasciences
Laval, CA · 3 known investors
Find your way into Altasciences
Sign up to see every warm intro you have to Altasciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Altasciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.
Founders & leadership
DB
Dr. Beatrice SetnikChief Scientific Officer
DG
Dr. Gaetano MorelliExecutive Vice President Medical Affairs, Chief Medical Officer
RS
Robert SabelliCo-Chief Operating OfficerRobert Sabelli is Co-Chief Operating Officer at Altasciences, where he oversees operations for the drug development platform. He brings over 25 years of experience in CRO leadership, clinical trials management, and drug development services including preclinical safety testing and clinical pharmacology.
JC
Julie-Ann CabanaChief Marketing OfficerJulie-Ann Cabana is Chief Marketing Officer at Altasciences and brings over 25 years of experience in the preclinical, clinical, and bioanalytical CRO industries, with expertise in executive leadership, commercial strategy, and scaling operations across North America and China.
MR
Mariano RodriguezExecutive Vice President and Chief Financial OfficerMariano Rodriguez is an Executive Vice President and Chief Financial Officer at Altasciences with over 25 years of experience in corporate finance, business development, and healthcare operations. He has led more than 15 acquisitions, partnerships, and divestitures, and completed over $900 million in equity and debt financing transactions for both private and public companies.
Investors · 3
Frequently asked questions
- What does Altasciences do?
- Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.
- Who are Altasciences's investors?
- Altasciences's investors include Novo Holdings, Kilmer Group, Signet Healthcare Partners.
- Where is Altasciences headquartered?
- Altasciences is headquartered in Laval, CA.